Scientific Information

Organising Institutions

The goal of the Fondazione Crescere Insieme Onlus is to research structural and organizational solutions aimed at promoting the humanization and familiarity of care and the psycho-physical well-being of the users of the service, namely children and their families, and all those who work daily in the Neonatal Intensive Care Unit of the Sant’Anna Hospital in Turin

Scientific Committee

Paolo Manzoni

Chair
Degli infermi Hospital Biella – Italy

Eduardo Bancalari

Co-chairman

Louis Bont

Co-chairman

 

Avroy Fanaroff

Co-chairman

Hans van Goudoever

Co-chairman

Paolo Manzoni

Chair
Degli infermi Hospital Biella – Italy

Eduardo Bancalari

Co-chairman

Louis Bont

Co-chairman

Avroy Fanaroff

Co-chairman

Hans van Goudoever

Co-chairman

Scientific Programme

12:00-13:15

Registration, welcome coffee and exhibit visit

13:15-13:30

Opening

Paolo Manzoni, Louis Bont

Opening lectures

13:30-14:00

Opening lectures: The year in review

Paolo Manzoni, Louis Bont

14:00-14:40

The human infant nose organoid (HNO) platform to study virus-host biology and for the evaluation of monoclonal antibody and other therapeutics: a specific model for assessing infants’ response to respiratory syncytial virus and SARS-CoV-2.  translating into pragmatical skills

Pedro A Piedra, USA

14:40-16:00

Symposium on the “Premature birth and the association with recurrent wheeze and asthma: the impact of early life RSV prevention”.

Chairman: Louis Bont
  • Mechanisms and background
    Renato Stein
  • The current evidence
    Eugenio Baraldi

16:00-16:45

Break exhibit visit

16:45-17:25

Composite, long-term sequelae of RSV-LRTI and potential impact of new interventions

Heather Zar, SAF

17:25-18:05

Molecular epidemiology of respirator viruses after the Covid pandemic

Thomas C. Williams, UK (virtual)

18:05-18:50

The RSV vaccines pipeline

Louis Bont, NED

18:50-19:00

Day closing remarks

Paolo Manzoni, Louis Bont

08:30-08:45

Opening

Paolo Manzoni, Louis Bont

08:45-09:20

The RSV burden in LMIC

Yvette Lowensteyn, NED

09:20-11:00

Mini symposium “Maternal vaccination for RSV – clinically measurable benefits”

  1. Latest updates and published evidence
    Luis Bont
  2. The Ob-Gyn perspective -
    Fernando Althabe, ARG
  3. The Neonatologist perspective
    Paolo Manzoni, ITA

11:00-11:15

Coffee Break- Exhibit walk

11:15-12:00

Astra Zeneca sponsored lecture : “RSV infection- a look back to the last 25 years”

O. Ramilo, USA
Chairman: Gianluca Lista, ITA

12:00-12:30

Overview of future vaccines for respiratory viruses in infancy

Marta Nunes

12:30-12:45

Closing remarks

Paolo Manzoni, Louis Bont

12:45-15:00

Exhibhit visit, ICCN registration, poster walk

15:00-15:15

ICCN Opening

Paolo Manzoni

15:15-15:45

Noise reduction and language development in the NICU – an unsolveable dilemma?

Angelika Berger, AUT

15:45-16:15

Game-changing opportunities to strengthen newborn research

Neena Modi, UK

16:15-16:45

Neonatal hypoglycemia, a never ending story

Nestor Vain, ARG

16:45-17:15

New protocols on diaphragmatic hernia

Ruben Bromiker, ISR

17:15-18:30

Platform presentation session: new science and ongoing research

  1. Neonatal morbidities and feeding tolerance outcomes in very preterm infants, be-fore and after introduction of probiotics supplementation. Stefan Johansson, SWE
  2. Caffeine use after NICU discharge: evidence from a retrospective analysis. Martin Chaffee, USA
  3. Increasing the use of OMM in the NiCU: An evidence-based initiative to increase use of own mothers milk in a NiCU: the impact of COVID -19. Rosalina Barroso, POR
  4. Palivizumab for the prevention of RSV infection in italian infants born at 29-35 wks g.a.: results from an up-to-date cost-effectiveness analysis.
    Barry Rodgers Gray, UK
  5. Ante-intrapartum risk factors for neonatal metabolic acidosis at birth.
    Alessandro Messina, IT
  6. National survey of ophtalmia neonatorum.
    Vito Mondì, IT
  7. RSV: a systematic review and metaanalysis of tomographic findings.
    Matteo Riccò, IT
  8. Validation of the international risk scoring tool for identifying moderate-to-late pre-term infants at greatest risk for severe RSV disease in Colombia.
    Nestor Vain ARG
  9. Maternal risk factors for RSV LRTI in otherwise healthy preterm and term infants: a systematic review.
    Barry Rodgers-Gray, UK

18:30-19:00

Human milk bank: from generalized to individualized nutrition

Manuel Sanchez Luna, SPA

19:00-19:15

Closing remarks

Paolo Manzoni

19:15

Networking dinner at the conference centre outdoor premises

09:00-09:30

Anti seizures drugs and role of electric and/or clinical seizures in newborns: all you need to know

Renato S Procianoy, BRA

09:30-10:00

Respiratory control issues, oxygenation instability and their impact on neonatal outcomes

Eduardo Bancalari, USA

10:00-10:30

Prevention and Treatment of necrotizing enterocolitis in preterm infants What is on the horizon?

Sanjay Patole, AUS

10:30-12:00

Break, exhibhit visit, poster walk

12:00-12:30

The role of lung ultrasound in NICU - an update

Daniele De Luca, FRA

12:30-13:00

The All-Four position at delivery and its possible impact on neonatal outcomes

Bianca Masturzo, ITA

13:00-14:30

Lunch break, exhibit visit, poster walk

14:30-16:00

Neonatal Neurology Symposium

Chair: Mohamed El-Dib, USA
Under the auspices and endorsement of the NBS - Newborn Brain Society (virtual only)
  • Neuroprotection in the term infant- current status and future directions
    Nikki Robertson, UK
  • Multimodality remote brain monitoring and outcomes
    Gabriel Variane, BRA

16:00-16:30

The Future of Neonatology

William Tarnow Mordi, AUS
collaborative plans to develop and disseminate the ENRICH Statement for Embedding Necessary Research Into Culture and Health

16:30-17:00

To close or not to close: new data on the management of PDA

Tim Hundscheid , NED

17:00-17:30

Closing remarks

Paolo Manzoni

Accreditations

CVS Ethical Medtech

11th ICCN International Conference on Clinical Neonatology starting on 07-07-2023 in Turin, Italy is COMPLIANT with the MedTech Europe Code of Ethical Business Practice.

More information: www.ethicalmedtech.eu